Literature DB >> 16694792

ANTIBODY FORMATION IN CASES OF LOBAR PNEUMONIA TREATED WITH SULFATHIAZOLE.

Y Kneeland1, B Mulliken.   

Abstract

Entities:  

Year:  1940        PMID: 16694792      PMCID: PMC435010          DOI: 10.1172/JCI101178

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  2 in total

1.  IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE.

Authors:  M Finland; W C Spring; F C Lowell
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

2.  ANTIBODY FORMATION IN CASES OF LOBAR PNEUMONIA TREATED WITH SULFAPYRIDINE.

Authors:  Y Kneeland; B Mulliken
Journal:  J Clin Invest       Date:  1940-03       Impact factor: 14.808

  2 in total
  5 in total

1.  A survey of primary infantile and juvenile pneumonia.

Authors:  M Elliott
Journal:  Arch Dis Child       Date:  1941-06       Impact factor: 3.791

2.  SPECIFIC ANTIPNEUMOCOCCAL IMMUNITY IN RELATION TO THE CHEMOTHERAPY OF PNEUMONIA.

Authors:  W S Tillett; M J Cambier; H Dunn
Journal:  J Clin Invest       Date:  1942-09       Impact factor: 14.808

3.  COMPLEMENT ACTIVITY IN PNEUMONIA.

Authors:  D D Rutstein; W H Walker
Journal:  J Clin Invest       Date:  1942-05       Impact factor: 14.808

4.  THE IMMUNE RESPONSE OF HUMAN BEINGS TO BRIEF INFECTIONS WITH PNEUMOCOCCUS.

Authors:  M Heidelberger; D G Anderson
Journal:  J Clin Invest       Date:  1944-09       Impact factor: 14.808

5.  THE EFFECT OF SULFAPYRIDINE UPON THE DEVELOPMENT OF IMMUNITY TO PNEUMOCOCCUS IN RABBITS.

Authors:  E C Curnen; C M Macleod
Journal:  J Exp Med       Date:  1942-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.